Open AccessBiologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database
Author(s) -
Takeo Hata,
Atsushi Hirata,
Ryosuke Ota,
Keiko Hosohata,
Masami Nishihara,
Masashi Neo,
Takahiro Katsumata
Publication year - 2022
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s375890
Subject(s) - medicine , adalimumab , tocilizumab , methotrexate , etanercept , antirheumatic drugs , database , disease , arthritis , epidemiology , abatacept , rheumatoid arthritis , pediatrics , antirheumatic agents , rituximab , lymphoma , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom